Package 70518-1550-0

{"route": ["ORAL"], "spl_id": "494c124c-6d02-4add-e063-6394a90a26f7", "openfda": {"nui": ["N0000175359", "N0000175419", "M0471776", "N0000000070", "N0000175561"], "unii": ["0J48LPH2TH", "J0E2756Z7N"], "rxcui": ["310793"], "spl_set_id": ["88aaa2a1-13be-4f56-ace6-66e899028007"], "pharm_class_cs": ["Thiazides [CS]"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]", "Angiotensin 2 Receptor Blocker [EPC]"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "manufacturer_name": ["REMEDYREPACK INC."]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (70518-1550-0)", "package_ndc": "70518-1550-0", "marketing_start_date": "20181018"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE, PLASTIC (70518-1550-1)", "package_ndc": "70518-1550-1", "marketing_start_date": "20250827"}], "brand_name": "Irbesartan and Hydrochlorothiazide", "product_id": "70518-1550_494c124c-6d02-4add-e063-6394a90a26f7", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Increased Diuresis [PE]", "Thiazide Diuretic [EPC]", "Thiazides [CS]"], "product_ndc": "70518-1550", "generic_name": "Irbesartan and Hydrochlorothiazide", "labeler_name": "REMEDYREPACK INC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irbesartan and Hydrochlorothiazide", "active_ingredients": [{"name": "HYDROCHLOROTHIAZIDE", "strength": "12.5 mg/1"}, {"name": "IRBESARTAN", "strength": "300 mg/1"}], "application_number": "ANDA203072", "marketing_category": "ANDA", "marketing_start_date": "20181018", "listing_expiration_date": "20271231"}